Hematopathology

Masters of Pathology Series

A comprehensive review of the updated WHO classification of hematopoietic neoplasms with special emphasis on new and changed criteria. Earn Lifelong Learning and SAM credits.

If your primary viewing mode will be on a computer or tablet, we recommend the Online Video package. In addition to online access, you will receive a USB with MP4 files. Use the USB to watch offline or import into iTunes and other media players and then synch to your mobile device, laptop or desktop. Plus you save $130 including standard shipping charges vs the DVD package.

    Video
695.0000
SKU: 282

Expert Hematopathology Insight

In addition to detailed coverage of hematopoietic neoplasms, the Masters of Pathology Series — Hematopathology program covers selected topics in hemostasis, thrombosis, and red blood cell pathology commonly encountered in pathology practices. Designed for both the practicing pathologist and the pathologist in training, this CME course will help you to better:

  • Use results of immunophenotypic, genetic, and molecular studies when diagnosing hematopoietic neoplasms
  • Interpret the diagnostic tests used to evaluate hemoglobinopathy, thalassemia, and selected hemostasis disorders
  • Understand practical aspects of new developments and updates as you prepare for exams or certification

Stay Current with Convenient CME

The Masters of Pathology Series - Hematopathology course is available online, so you can earn credits from the comfort of your home or office. This CME program provides you with a maximum of 11.50 AMA PRA Category 1 Credits. This program has been registered as a Lifelong Learning (Part II) and Self-Assessment Module (SAM) to offer 11.50 credits in the American Board of Pathology's (ABPath) Continuing Certification program.

View our full list of Topics/Speakers, Faculty, Accreditation and Media Format information.

  • Acute Myeloid Leukemia - Sharad C. Mathur, MD
  • Benign and Reactive Conditions of Lymph Nodes - Dennis P. O'Malley, MD
  • Myeloproliferative Neoplasms - Sharad C. Mathur, MD
  • Myelodysplastic Syndromes - Sharad C. Mathur, MD
  • B-cell Neoplasms of Small Lymphocyte Size - Sharad C. Mathur, MD
  • Aggressive B-cell Neoplasms - Dennis P. O'Malley, MD
  • Hodgkin Lymphoma - Sharad C. Mathur, MD
  • Immunosecretory Disorders - Sharad C. Mathur, MD
  • Overview of T Cell Lymphomas - Dennis P. O'Malley, MD
  • Lymphoblastic Leukemias, Lymphomas and Related Diseases - Dennis P. O'Malley, MD
  • Overview of the Spleen - Dennis P. O'Malley, MD
  • Hemoglobinopathies and Thalassemias - Sharad C. Mathur, MD
  • Selected Topics in Hemostasis - Sharad C. Mathur, MD

Course Director

Sharad C. Mathur, MD

  • Professor, Department of Pathology and Laboratory Medicine
  • University of Kansas Medical Center
  • Chief, Pathology and Laboratory Medicine Service
  • Kansas City VA Medical Center
  • Kansas City, MO

Faculty

Dennis P. O'Malley, MD

  • Adjunct Associate Professor
  • University of Texas
  • MD Anderson Cancer Center
  • Houston, TX

Accreditation Statement

Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

Oakstone Publishing, LLC designates this enduring material for a maximum of 11.50 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Masters of Pathology Series – Hematopathology has been registered as a Lifelong Learning (Part II) and Self-Assessment Module (SAM) to offer 11.50 credits in the American Board of Pathology's (ABPath) Continuing Certification program.

Date of Original Release: July 15, 2018
Date Credits Expire: July 15, 2021
Estimated time to complete this activity: 11.5 hours

CME credit is awarded upon successful completion of a course evaluation and a post-test.

Learning Objectives

After viewing this program, the participant will be better able to:

  • Describe the current WHO diagnostic criteria for the diagnosis of hematopoietic neoplasms
  • Correctly utilize and interpret results of immunophenotypic, genetic, and molecular studies in the diagnosis and classification of hematopoietic neoplasms
  • Summarize and correctly interpret diagnostic tests utilized in the evaluation of hemoglobinopathy, thalassemia, and selected disorders of hemostasis

Intended Audience

The program is designed both for practicing pathologists and for pathologists-in-training with emphasis on practical aspects of novel developments and updates for preparation for board examinations and maintenance of certification.